+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Postherpetic Neuralgia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768182
  • Report
  • April 2019
  • Region: Global
  • 101 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Allergan Plc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Postherpetic Neuralgia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Postherpetic Neuralgia. It presents in-depth analysis of Postherpetic Neuralgia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Postherpetic Neuralgia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Postherpetic Neuralgia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Postherpetic Neuralgia

The research work is prepared through extensive and continuous research on Postherpetic Neuralgia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Postherpetic Neuralgia patients are identified
  • The report includes panorama of Postherpetic Neuralgia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Postherpetic Neuralgia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Allergan Plc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Postherpetic Neuralgia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Postherpetic Neuralgia Clinical Trials by Region
2.2.2 Average Enrollment of Postherpetic Neuralgia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Postherpetic Neuralgia Treatment, 2019

3. Region wise Postherpetic Neuralgia Clinical Trials
3.1 Asia Pacific Postherpetic Neuralgia Clinical Trials by Country
3.2 Europe Postherpetic Neuralgia Clinical Trials by Country
3.3 North America Postherpetic Neuralgia Clinical Trials by Country
3.4 Middle East and Africa Postherpetic Neuralgia Clinical Trials by Country
3.5 South and Central America Postherpetic Neuralgia Clinical Trials by Country

4. Postherpetic Neuralgia Clinical Trial Trends
4.1 Start Year wise Postherpetic Neuralgia Clinical Trials
4.2 Phase wise Postherpetic Neuralgia Clinical Trials
4.3 Trial Status wise Postherpetic Neuralgia Clinical Trials
4.4 Trial Type wise Postherpetic Neuralgia Clinical Trials

5. Postherpetic Neuralgia Average Enrollment Trends
5.1 Average Enrollment in Postherpetic Neuralgia Trials by Year
5.2 Average Enrollment in Postherpetic Neuralgia Trials by Phase
5.3 Average Enrollment in Postherpetic Neuralgia Trials by Status
5.4 Average Enrollment in Postherpetic Neuralgia Trials by Type of Trial

6. Companies Participating in Postherpetic Neuralgia Clinical Trials
6.1 Postherpetic Neuralgia Trials by Sponsor Type
6.2 Postherpetic Neuralgia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Postherpetic Neuralgia Trials- Phase 1
7.2 Postherpetic Neuralgia Trials- Phase 2
7.3 Postherpetic Neuralgia Trials- Phase 3
7.4 Postherpetic Neuralgia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Postherpetic Neuralgia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 7: North America - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 9: Postherpetic Neuralgia Clinical Trials by Phase
Figure 10: Postherpetic Neuralgia Clinical Trials by Trial Status
Figure 11: Postherpetic Neuralgia Clinical Trials by Type
Figure 12: Postherpetic Neuralgia Clinical Trials by Sponsor Type
Figure 13: Postherpetic Neuralgia Clinical Trials by Leading Sponsors
Figure 14: Postherpetic Neuralgia Average Enrollment by Phase
Figure 15: Postherpetic Neuralgia Average Enrollment by Trial Status
Figure 16: Postherpetic Neuralgia Average Enrollment by Type
Figure 17: Postherpetic Neuralgia- Average Enrolment by Type of Sponsors
Figure 18: Postherpetic Neuralgia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Postherpetic Neuralgia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Table 5: Europe - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Table 7: North America - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Postherpetic Neuralgia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Postherpetic Neuralgia Average Enrollment by Phase
Table 15: Postherpetic Neuralgia Average Enrollment by Trial Status
Table 16: Postherpetic Neuralgia Average Enrollment by Type
Table 17: Postherpetic Neuralgia- Average Enrolment by Type of Sponsors
Table 18: Postherpetic Neuralgia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acorda Therapeutics Inc
  • Allergan Plc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Relmada Therapeutics Inc
  • Sun Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
Adroll
adroll